U.S. HHS Seeks Stakeholder COVID-19 Countermeasures

The U.S. Department of Health & Human Services is providing a portal for the COVID-19 medical countermeasures task force as a single point of entry for the submission of market research packages and meeting requests from interested stakeholders.

The U.S. government, in response to the COVID-19 outbreak, is seeking information from stakeholders on available medical countermeasures in development, particularly products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform.

The submission requires a brief product or technology description, along with a slide deck, manuscript, publications, or other non-confidential information. It also notes that any information presented as market research, submission is no guarantee of a meeting or funding and will be shared across U.S. Government agencies involved in COVID-19 medical countermeasure R&D. Only U.S. government officials are invited to join a CoronaWatch meeting, and are bound by law to maintain confidentiality of what is presented and discussed.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.